These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25103530)

  • 1. A Chinese herbal Formula, Chang-Wei-Qin, Synergistically Enhances Antitumor Effect of Oxaliplatin.
    Zhang Y; Zhang Q; Fan Z; Sun J; Liu X; Cheng L; Li A; Xu J
    Pathol Oncol Res; 2015 Apr; 21(2):389-97. PubMed ID: 25103530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxymatrine synergistically enhances antitumor activity of oxaliplatin in colon carcinoma through PI3K/AKT/mTOR pathway.
    Liu Y; Bi T; Wang Z; Wu G; Qian L; Gao Q; Shen G
    Apoptosis; 2016 Dec; 21(12):1398-1407. PubMed ID: 27671687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new herbal formula BP10A exerted an antitumor effect and enhanced anticancer effect of irinotecan and oxaliplatin in the colon cancer PDTX model.
    Kim J; Kim HY; Hong S; Shin S; Kim YA; Kim NS; Bang OS
    Biomed Pharmacother; 2019 Aug; 116():108987. PubMed ID: 31112870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chang-wei-qing, a Chinese herbal formula, ameliorates colitis-associated tumour development via inhibiting NF-κB and STAT3 signalling pathway.
    Wan G; Xie M; Zhang X; Li M
    Pharm Biol; 2019 Dec; 57(1):231-237. PubMed ID: 30905249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triptolide synergistically enhances antitumor activity of oxaliplatin in colon carcinoma in vitro and in vivo.
    Liu Y; Xiao E; Yuan L; Li G
    DNA Cell Biol; 2014 Jul; 33(7):418-25. PubMed ID: 24720675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells.
    Plasencia C; Martínez-Balibrea E; Martinez-Cardús A; Quinn DI; Abad A; Neamati N
    Int J Oncol; 2006 Jul; 29(1):225-35. PubMed ID: 16773204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of medicated serum prepared with Chinese herbal medicine Changweiqing on pharmacokinetics of oxaliplatin in colon cancer cells].
    Zhang Y; Sun XW; Xu JH; Lu H; Fan ZZ; Sun J; Zhang XX
    Zhong Xi Yi Jie He Xue Bao; 2012 Aug; 10(8):901-10. PubMed ID: 22883407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual hepatocellular carcinoma after oxaliplatin treatment has increased metastatic potential in a nude mouse model and is attenuated by Songyou Yin.
    Xiong W; Ren ZG; Qiu SJ; Sun HC; Wang L; Liu BB; Li QS; Zhang W; Zhu XD; Liu L; Wang WQ; Tang ZY
    BMC Cancer; 2010 May; 10():219. PubMed ID: 20487542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Cryptoxanthin Synergistically Enhances the Antitumoral Activity of Oxaliplatin through ΔNP73 Negative Regulation in Colon Cancer.
    San Millán C; Soldevilla B; Martín P; Gil-Calderón B; Compte M; Pérez-Sacristán B; Donoso E; Peña C; Romero J; Granado-Lorencio F; Bonilla F; Domínguez G
    Clin Cancer Res; 2015 Oct; 21(19):4398-409. PubMed ID: 26023082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. γ-Aminobutyric acid inhibits the proliferation and increases oxaliplatin sensitivity in human colon cancer cells.
    Song L; Du A; Xiong Y; Jiang J; Zhang Y; Tian Z; Yan H
    Tumour Biol; 2016 Nov; 37(11):14885-14894. PubMed ID: 27644246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic basis of a combination D-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo.
    Chen SJ; Kuo CC; Pan HY; Tsou TC; Yeh SC; Chang JY
    Biochem Pharmacol; 2015 May; 95(1):28-37. PubMed ID: 25801007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models.
    Ning Y; Labonte MJ; Zhang W; Bohanes PO; Gerger A; Yang D; Benhaim L; Paez D; Rosenberg DO; Nagulapalli Venkata KC; Louie SG; Petasis NA; Ladner RD; Lenz HJ
    Mol Cancer Ther; 2012 Jun; 11(6):1353-64. PubMed ID: 22391039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gegen Qinlian Decoction reverses oxaliplatin resistance in colorectal cancer by inhibiting YTHDF1-regulated m6A modification of GLS1.
    Lin X; Xu L; Gu M; Shao H; Yao L; Huang X
    Phytomedicine; 2024 Oct; 133():155906. PubMed ID: 39089089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herbal formula Huang Qin Ge Gen Tang enhances 5-fluorouracil antitumor activity through modulation of the E2F1/TS pathway.
    Liu H; Liu H; Zhou Z; Parise RA; Chu E; Schmitz JC
    Cell Commun Signal; 2018 Feb; 16(1):7. PubMed ID: 29458395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sirtuin inhibitor tenovin-6 upregulates death receptor 5 and enhances cytotoxic effects of 5-fluorouracil and oxaliplatin in colon cancer cells.
    Ueno T; Endo S; Saito R; Hirose M; Hirai S; Suzuki H; Yamato K; Hyodo I
    Oncol Res; 2013; 21(3):155-64. PubMed ID: 24512730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression MGP inhibits tumor proliferation and reverses oxaliplatin resistance in colorectal cancer.
    Huang C; Wang M; Wang J; Wu D; Gao Y; Huang K; Yao X
    Biochem Pharmacol; 2021 Jul; 189():114390. PubMed ID: 33359068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy.
    Tan S; Shi H; Ba M; Lin S; Tang H; Zeng X; Zhang X
    Int J Mol Med; 2016 Apr; 37(4):1030-8. PubMed ID: 26935807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxaliplatin lipidated prodrug synergistically enhances the anti-colorectal cancer effect of IL12 mRNA.
    Liu H; Du Y; Zhan D; Yu W; Li Y; Wang A; Yin J; Cao H; Fu Y
    Drug Deliv Transl Res; 2024 Nov; 14(11):3186-3199. PubMed ID: 38457025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Lipophilic Pt(IV) Oxaliplatin Derivative Enhances Antitumor Activity.
    Abu Ammar A; Raveendran R; Gibson D; Nassar T; Benita S
    J Med Chem; 2016 Oct; 59(19):9035-9046. PubMed ID: 27603506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of an adenovirus harboring human IL-24 in colon cancer.
    Chang S; Yang J; Chen W; Xie Y; Sheng W
    Mol Biol Rep; 2011 Jan; 38(1):395-401. PubMed ID: 20354907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.